No
|
TR-484
|
111-76-2 |
2-Butoxyethanol (ethylene glycol monobutyl ether) |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 3/50 4/50 1/49 8/49
|
May Have Been Related
|
No
|
TR-484
|
111-76-2 |
2-Butoxyethanol (ethylene glycol monobutyl ether) |
Mice |
B6C3F1 |
Male |
Inhalation |
Forestomach
|
Some Evidence |
Equivocal Evidence |
SQUAMOUS CELL PAPILLOMA 1/50 1/50 2/49 2/49
|
May Have Been Related
|
No
|
TR-484
|
111-76-2 |
2-Butoxyethanol (ethylene glycol monobutyl ether) |
Mice |
B6C3F1 |
Female |
Inhalation |
Forestomach
|
Some Evidence |
Some Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 1/50 2/50 5/50 COMBINED 0/50 1/50 2/50 6/50
|
Neoplastic Lesions
|
No
|
TR-484
|
111-76-2 |
2-Butoxyethanol (ethylene glycol monobutyl ether) |
Mice |
B6C3F1 |
Male |
Inhalation |
Liver
|
Some Evidence |
Equivocal Evidence |
HEPATOCELLULAR CARCINOMA 10/50 11/50 16/49 21/49
|
May Have Been Related
|
Yes
|
TR-484
|
111-76-2 |
2-Butoxyethanol (ethylene glycol monobutyl ether) |
Mice |
B6C3F1 |
Male |
Inhalation |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 0/50 1/50 2/49 4/49
|
Neoplastic Lesions
|
No
|
TR-026
|
1836-75-5 |
Nitrofen |
Rats |
Osborne Mendel |
Male |
Dosed-Feed |
Unspecified
|
Inadequate Study |
|
Not applicable
|
Not applicable
|
No
|
TR-026
|
1836-75-5 |
Nitrofen |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Positive |
Positive |
HEPATOCELLULAR CARCINOMA
|
Neoplastic Lesions
|
No
|
TR-026
|
1836-75-5 |
Nitrofen |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Positive |
Positive |
HEPATOCELLULAR CARCINOMA
|
Neoplastic Lesions
|
No
|
TR-026
|
1836-75-5 |
Nitrofen |
Rats |
Osborne Mendel |
Female |
Dosed-Feed |
Pancreas Acinar Cell
|
Positive |
Positive |
CARCINOMA
|
Neoplastic Lesions
|
Yes
|
TR-026
|
1836-75-5 |
Nitrofen |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Liver)
|
Positive |
Positive |
HEMANGIOSARCOMA
|
Neoplastic Lesions
|
Yes
|
TR-026
|
1836-75-5 |
Nitrofen |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Vascular System (Liver)
|
Positive |
Positive |
HEMANGIOSARCOMA
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Female |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 13/49 14/48 15/48 26/49
|
May Have Been Related
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 2/50 3/50 1/50 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 9/50 15/49 10/50 44/50 OR CARCINOMA 3/50 7/49 11/50 17/50 COMBINED 11/50 21/49 20/50 21/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Spleen
|
Clear Evidence |
Clear Evidence |
FIBROSARCOMA 0/49 1/50 2/50 17/50, HEMANGIOSARCOMA 0/49 0/50 0/50 4/50, OR OSTEOSARCOMA 0/49 0/50 1/50 19/50 COMBINED 0/49 1/50 3/50 38/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Spleen
|
Equivocal Evidence |
Equivocal Evidence |
FIBROSARCOMA 0/50 0/50 1/50 0/50 OR OSTEOSARCOMA 0/50 0/50 0/50 1/50 COMBINED 0/50 0/50 1/50 1/50
|
Neoplastic Lesions
|
Yes
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 2/50 2/50 1/49 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Spleen)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 3/50 2/47 0/49 5/49
|
Neoplastic Lesions
|
No
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
Pheochromocytoma 3/50 7/50 9/50
|
Neoplastic Lesions
|
No
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Mice |
B6C3F1 |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
Pheochromocytoma 0/50 4/50 7/48
|
Neoplastic Lesions
|
No
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
Pheochromocytoma 12/50 17/50 23/50 15/48 or malignant pheochromocytoma 3/50 2/50 4/50 0/48 combined 15/50 18/50 25/50 15/48
|
Neoplastic Lesions
|
Yes
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
Hemangiosarcoma 2/50 8/50 10/50
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/35 2/49 2/46 38/49
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/34 4/48 21/48 44/49 OR MALIGNANT PHEOCHROMOCYTOMA 1/34 0/48 0/48 3/49 COMBINED 1/34 4/48 21/48 45/49
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/34 3/50 6/49 30/48 OR CARCINOMA 0/34 1/50 0/49 1/48 COMBINED 1/34 4/50 6/49 31/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/35 13/48 17/48 32/49 OR CARCINOMA 1/35 7/48 7/48 9/49 COMBINED 6/35 19/48 21/48 34/49
|
Neoplastic Lesions
|
Yes
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Liver)
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/34 1/50 1/49 8/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Spleen)
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/34 0/50 2/50 2/47
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/31 10/45 23/45
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/32 20/47 33/48 OR CARCINOMA 2/32 10/47 12/48 COMBINED 7/32 26/47 37/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 3/33 8/49 8/50 OR CARCINOMA 0/33 1/49 1/50 COMBINED 3/33 9/49 9/50
|
Neoplastic Lesions
|
Yes
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 0/33 2/49 4/50
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Spleen)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 0/33 1/50 3/47
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Male |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Equivocal Evidence |
MONONUCLEAR CELL LEUKEMIA: 34/50 43/50 38/50 31/50
|
May Have Been Related
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Female |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
HISTIOCYTIC SARCOMA 1/48 21/48 19/47 18/48
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Male |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
HISTIOCYTIC SARCOMA 0/48 12/48 7/48 7/48
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Female |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
MONONUCLEAR CELL LEUKEMIA: 16/50 31/50 23/50 36/50
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Female |
Inhalation |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
SINGLE SECTIONS: ADENOMA 0/50 3/50 1/50 3/50 OR CARCINOMA 0/50 0/50 0/50 2/50 COMBINED 0/50 3/50 1/50 5/50; SINGLE AND STEP SECTIONS: ADENOMA 0/50 3/50 3/50 8/50 OR CARCINOMA 0/50 0/50 0/50 3/50 COMBINED 0/50 3/50 3/50 10/50
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Male |
Inhalation |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
SINGLE SECTIONS: ADENOMA 0/50 0/50 6/50 3/50 OR CARCINOMA 1/50 0/50 2/50 0/50 COMBINED 1/50 0/50 6/50 3/50; SINGLE AND STEP SECTIONS: ADENOMA 2/50 4/50 9/50 13/50 OR CARCINOMA 1/50 1/50 2/50 0/50 COMBINED 3/50 5/50 9/50 13/50
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 15/48 17/48 20/47 15/47 OR CARCINOMA 4/48 28/48 22/47 20/47 COMBINED 17/48 33/48 29/47 28/47
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Male |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 17/48 17/48 12/48 20/48 OR CARCINOMA 11/48 20/48 33/48 26/48 COMBINED 26/48 34/48 39/48 35/48
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 4/50 5/50 6/50 OR CARCINOMA 0/50 4/50 9/50 2/50 COMBINED 0/50 7/50 12/50 8/50
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Male |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 3/50 6/50 8/50 5/50 OR CARCINOMA 1/50 1/50 10/50 3/50 COMBINED 4/50 7/50 15/50 8/50
|
Neoplastic Lesions
|
No
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Male |
Inhalation |
Testis
|
Clear Evidence |
Equivocal Evidence |
INTERSTITIAL CELL ADENOMA 39/50 40/50 48/50 47/50
|
May Have Been Related
|
Yes
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Female |
Inhalation |
Vascular System (Liver)
|
Clear Evidence |
Clear Evidence |
HEMANGIOMA 0/48 5/48 2/47 1/47 OR HEMANGIOSARCOMA 0/48 27/48 27/47 34/47 COMBINED 0/48 31/48 28/47 35/47
|
Neoplastic Lesions
|
Yes
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Mice |
B6C3F1 |
Male |
Inhalation |
Vascular System (Liver)
|
Clear Evidence |
Clear Evidence |
HEMANGIOMA 0/48 10/48 5/48 2/48 OR HEMANGIOSARCOMA 0/48 21/48 27/48 37/48 COMBINED 0/48 26/48 30/48 38/48
|
Neoplastic Lesions
|
Yes
|
TR-450
|
116-14-3 |
Tetrafluoroethylene |
Rats |
F344/N |
Female |
Inhalation |
Vascular System (Liver)
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/50 0/50 5/50 1/50
|
Neoplastic Lesions
|